Sanofi(Beijing) Pharmaceutical Co., Ltd., 7,XINGSHENG STREET,BEIJING ECONOMIC & TECHNOLOGIC BEIJING ECONOMIC & TECHNOLOGICAL DEVELOPMENT ZONE BEIJING MUNICIPALITY | Buyer Report — Panjiva
MENU

Supply Chain Intelligence about:

Sanofi(Beijing) Pharmaceutical Co., Ltd.

Company profile   China

See Sanofi(Beijing) Pharmaceutical Co., Ltd.'s products and suppliers

Thousands of companies like you use Panjiva to research suppliers and competitors.

Reveal patterns in global trade

Top countries/regions that supply Sanofi(Beijing) Pharmaceutical Co., Ltd.
Origin Country/Region
  • Germany
    488 shipments (54.4%)
  • France
    115 shipments (12.8%)
  • Italy
    87 shipments (9.7%)
  • Finland
    62 shipments (6.9%)
  • Switzerland
    43 shipments (4.8%)
  • Spain
    30 shipments (3.3%)
  • Czech Republic
    18 shipments (2.0%)
  • Japan
    11 shipments (1.2%)
  • United Kingdom
    11 shipments (1.2%)
  • China
    8 shipments (0.9%)
  • United States
    7 shipments (0.8%)
  • Hong Kong (SAR, China)
    6 shipments (0.7%)
  • South Korea
    4 shipments (0.4%)
  • Ireland
    2 shipments (0.2%)
  • Taiwan (China)
    1 shipments (0.1%)
  • Sweden
    1 shipments (0.1%)
  • Singapore
    1 shipments (0.1%)
  • Poland
    1 shipments (0.1%)
  • Hungary
    1 shipments (0.1%)

Easy access to trade data

See Chinese trade for Sanofi(Beijing) Pharmaceutical Co., Ltd.

Complete coverage for 116 HS codes. Chinese Trade Data is another data source separate from US import data. It includes HS product codes and with their dollar values. What are HS codes?
Shipments Total value HS Commodity Description
167 $1,216,416,354
3004.31
Containing insulin
118 $53,732,133
3926.90
Other:
87 $155,986,243
3004.90
Other:
Chinese Trade Data includes product codes, revenue, and mode of transportation. Learn more

Contact information for Sanofi(Beijing) Pharmaceutical Co., Ltd.

 
Address
7,XINGSHENG STREET,BEIJING ECONOMIC & TECHNOLOGIC BEIJING ECONOMIC & TECHNOLOGICAL DEVELOPMENT ZONE BEIJING MUNICIPALITY
 
 

Recent Panjiva Research about Sanofi(Beijing) Pharmaceutical Co., Ltd.

20161202-insulin-us

Novo and Lilly Face Tough Growth in Diabetes, Trade Data Shows

The global prevalence of diabetes is growing, but can be a tough sector for pharmaceutical companies to make money in as recent results from Novo Nordisk and Eli Lilly demonstrate. Panjiva data shows that U.S. imports of insulin and related equipment fell 15% in the third quarter in dollar ter... Read more →